SciNeuro Pharmaceuticals is an innovation-driven, neuroscience-focused biopharmaceutical company with an established pipeline of novel therapeutic candidates to address neurodegenerative and other CNS diseases. The company focuses on targets that are supported by human biology and which play a critical role in regulating foundation biology, to achieve better probability of success in clinical development. SciNeuro is committed to delivering medicines that can make a difference to improve the lives of patients around the world, transforming scientific discoveries into groundbreaking therapies.
Location: United States, Maryland, Rockville
Employees: 11-50
Founded date: 2020
Investors 1
| Date | Name | Website |
| - | ARCH Ventu... | archventur... |
Mentions in press and media 1
| Date | Title | Description | Source |
| - | Investors have poured $548 million into neuroscience biotech... | Peter Anastasiou, the CEO of Capsida Biotherapeutics. Capsida Biotherapeutics This story is availabl... | businessin... |